Does GEFITINIB Cause Metastases to bone? 147 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 147 reports of Metastases to bone have been filed in association with GEFITINIB (Gefitinib). This represents 3.1% of all adverse event reports for GEFITINIB.
147
Reports of Metastases to bone with GEFITINIB
3.1%
of all GEFITINIB reports
19
Deaths
14
Hospitalizations
How Dangerous Is Metastases to bone From GEFITINIB?
Of the 147 reports, 19 (12.9%) resulted in death, 14 (9.5%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEFITINIB. However, 147 reports have been filed with the FAERS database.
What Other Side Effects Does GEFITINIB Cause?
Malignant neoplasm progression (1,651)
Drug resistance (1,228)
Death (590)
Diarrhoea (393)
Rash (318)
Metastases to central nervous system (306)
Acquired gene mutation (250)
Disease progression (244)
Drug ineffective (197)
Off label use (166)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which GEFITINIB Alternatives Have Lower Metastases to bone Risk?
GEFITINIB vs GELATIN
GEFITINIB vs GEMCITABINE
GEFITINIB vs GEMCITABINE\GEMCITABINE
GEFITINIB vs GEMFIBROZIL
GEFITINIB vs GEMTUZUMAB OZOGAMICIN